Sheldon Sloan insider trades
Open-market stock purchases and sales by Sheldon Sloan, Chief Medical Officer at Spyre Therapeutics, Inc, from SEC Form 4 filings since Oct 1, 2024.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jul 1, 2026 | SYRE Spyre Therapeutics, Inc | Sold | $569K |
| Jul 1, 2026 | SYRE Spyre Therapeutics, Inc | Sold | $162K |
| Jul 1, 2026 | SYRE Spyre Therapeutics, Inc | Bought (not open market) | $229K |
| Jul 1, 2026 | SYRE Spyre Therapeutics, Inc | Bought (not open market) | — |
| Jun 3, 2026 | SYRE Spyre Therapeutics, Inc | Bought (not open market) | — |
| Jun 3, 2026 | SYRE Spyre Therapeutics, Inc | Sold | $625K |
| May 1, 2026 | SYRE Spyre Therapeutics, Inc | Sold | $1.5M |
| May 1, 2026 | SYRE Spyre Therapeutics, Inc | Sold | $1.4M |
| May 1, 2026 | SYRE Spyre Therapeutics, Inc | Sold | $628K |
| May 1, 2026 | SYRE Spyre Therapeutics, Inc | Sold | $764K |
| May 1, 2026 | SYRE Spyre Therapeutics, Inc | Sold | $377K |
| May 1, 2026 | SYRE Spyre Therapeutics, Inc | Sold | $30.1K |
| May 1, 2026 | SYRE Spyre Therapeutics, Inc | Bought (not open market) | — |
| May 1, 2026 | SYRE Spyre Therapeutics, Inc | Sold | $932K |
| Apr 1, 2026 | SYRE Spyre Therapeutics, Inc | Sold | $398K |
| Apr 1, 2026 | SYRE Spyre Therapeutics, Inc | Bought (not open market) | — |
| Jan 9, 2026 | SYRE Spyre Therapeutics, Inc | Bought (not open market) | — |
Companies traded
- SYRE Spyre Therapeutics, Inc: 11 sales, last Jul 1, 2026